| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |